Optometrists in Glasgow, MT Accepting Medicare
6 Optometrists found. Showing 1 - 6
 Hi-line Eye Care, Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 234 5th St S, Glasgow, MT 59230 Phone: 406-228-4895 Fax: 406-228-9760 |
Glasgow Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 839 1st Ave S, Glasgow, MT 59230 Phone: 406-365-8231 Fax: 406-365-7081 |
Jon Kolstad O D, P C Optometrist Medicare: Medicare Enrolled Practice Location: 630 3rd Ave S, Glasgow, MT 59230 Phone: 406-228-8641 Fax: 406-228-2094 |
 Jon C Kolstad, OD PC Optometrist Medicare: Accepting Medicare Assignments Practice Location: 630 3rd Ave S, Glasgow, MT 59230 Phone: 406-228-8641 Fax: 406-228-2094 |
Jon C Kolstad Od, Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 630 3rd Ave S, Glasgow, MT 59230 Phone: 406-228-8641 Fax: 406-228-2094 |
Glasgow Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 839 1st Ave S, Glasgow, MT 59230 Phone: 406-228-8200 Fax: 406-228-8200 |
News Archive
High salt consumption does not seem to increase risk of heart disease
A new eight year long European study concludes that salt consumption is not dangerous and may in fact be beneficial. This is certainly contrary to advice from American Medical Association, American Heart Association and the Center for Disease Control and Prevention, which says higher sodium consumption can increase the risk of heart disease.
Preventing transfusion-transmitted infections through improved blood screening methods
The blood transfusion community should consider pathogen inactivation methods as an alternative way to assure the safety and availability of the nation's blood supply, a pathologist wrote in the December issue of the American Journal of Clinical Pathology (AJCP).
New understanding of neural basis for decision making, or free will
The area of the brain responsible for self-control, where the decision not to do something occurs after thinking about doing it, is separate from the area associated with taking action, scientists say in the August 22 issue of The Journal of Neuroscience.
Allo-HSCT Non-Relapse Related Mortality Reduction Revealed
A reduction in the risks of infection- and organ failure-related death has driven an improvement in non-relapse mortality among recipients of allogeneic haematopoietic stem cell transplantation, Japanese research suggests.
Anacor, DNDi and SCYNEXIS complete SCYX-7158 pre-clinical studies for combating sleeping sickness
Anacor Pharmaceuticals, the Drugs for Neglected Diseases initiative (DNDi), and SCYNEXIS Inc. today announced the successful completion of pre-clinical studies for the first new oral drug candidate discovered specifically to combat human African trypanosomiasis (HAT), also known as sleeping sickness.
› Verified 8 days ago
Optometrists
Chiropractors
Physical Therapists
Occupational Therapists
Speech-Language Pathologists